Scientific Sessions 2025  /  Innovation in Quality – Heart Failure  /  Leveraging the Target: Aortic Stenosis Program for Active Surveillance in AS
Logo

American Heart Association

  43
  0

Final ID:

Leveraging the Target: Aortic Stenosis Program for Active Surveillance in AS

  • Vemulapalli, Sreekanth  ( duke university , Durham , North Carolina , United States )
    • Author Disclosures:
    Sreekanth Vemulapalli: DO have relevant financial relationships ; Consultant:Abbott Vascular:Active (exists now) ; Advisor:Boehringer-Ingelheim:Past (completed) ; Advisor:Astra Zeneca:Past (completed) ; Consultant:Medtronic:Active (exists now) ; Advisor:Edwards Lifesciences:Past (completed) ; Speaker:Edwards Lifesciences:Past (completed) ; Research Funding (PI or named investigator):Edwards LIfesciences:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovation in Quality – Heart Failure

Monday, 11/10/2025 , 09:45AM - 11:00AM

Special Focus

More abstracts on this topic:
Transforming Treatment in ATTR-CM

Maurer Mathew

Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead

Tang Amber

More abstracts from these authors:
Living on Borrowed Time: A Call to Action for Severe Aortic Stenosis Patients

Vemulapalli Sreekanth, Pop Andrei, Strom Jordan

Contemporary Diagnosis, Management, and Outcomes of Patients With Low-Gradient Severe Aortic Stenosis: A Multi-Center Analysis

Vemulapalli Sreekanth, Genereux Philippe, Lindman Brian, Elmariah Sammy, Pibarot Philippe, Peterson Benjamin, Rodriguez Evelio, Leon Martin, Mack Michael, Eberst Kyle

You have to be authorized to contact abstract author. Please, Login
Not Available